SCHEMBL7430237

SCHEMBL7430237

O=C1Nc2ccccc2CCC1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.52
MAPK13 O15264 1/20 0.52
MAPK12 P53778 1/20 0.52
MAPK11 Q15759 1/20 0.52
MAPK14 Q16539 1/20 0.52
MAPT P10636 1/20 0.49
PYGL P06737 5/20 0.47
PYGM P11217 5/20 0.47
AHR P35869 1/20 0.44
PDK2 Q15119 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
BRD4 O60885 2/20 0.41
CREBBP Q92793 2/20 0.41
RIPK1 Q13546 2/20 0.40
SRC P12931 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8882577 0.80 OTUD7B (0.44) NPC1MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL859143 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL12598688 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL4700977 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL2214341 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1270022 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL2608569 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL13904707 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL22048708 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1270418 0.79 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113292495-B Synthesis method of (S) -amino compound 迪嘉药业集团有限公司 2022-09-13 CN disclosed
CN-113292495-A Synthesis method of (S) -amino compound 迪嘉药业集团有限公司 2021-08-24 CN disclosed
EP-0119954-B1 3-AMINO-1-BENZAZEPIN-2-ONE-1-ALCANOIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL PREPARATION AS WELL AS THEIR THERAPEUTIC USE CIBA-GEIGY AG (CH) 1990-03-14 EP disclosed
EP-0119955-B1 3-(5-AMINOPENTYL)-AMINO-1-BENZAZEPIN-2-ONE-1-ALCANOIC ACIDS, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL PREPARATION AS WELL AS THEIR THERAPEUTIC USE CIBA-GEIGY AG (CH) 1989-12-13 EP disclosed
US-4575503-A ANGIOTENSIN CONVERTING ENZYME INHIBITOR, HYPOTENSIVE CIBA-GEIGY CORPORATION (US) 1986-03-11 US disclosed
EP-0119955-A2 3-(5-Aminopentyl)-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use CIBA-GEIGY AG (CH) 1984-09-26 EP disclosed
EP-0119954-A2 3-Amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use CIBA-GEIGY AG (CH) 1984-09-26 EP disclosed
US-4473575-A ANGIOTENSIN INHIBITORS, HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1984-09-25 US disclosed
US-4410520-A ANGIOTENSION CONVERTING ENZYME INGIBITOR, HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1983-10-18 US disclosed
EP-0072352-A1 Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use CIBA-GEIGY AG (CH) 1983-02-16 EP disclosed